Alkermes (ALKS) EV to EBITDA (2010 - 2026)
Alkermes (ALKS) EV to EBITDA (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EV to EBITDA |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 36.44 Bn | 32.71 Bn | 1.97 Bn | 14.29 |
| 2 | Zoetis | 33.18 Bn | 31.24 Bn | 1.62 Bn | 8.54 |
| 3 | United Therapeutics | 23.36 Bn | 21.20 Bn | 648.10 Mn | 14.77 |
| 4 | Neurocrine Biosciences | 15.90 Bn | 14.58 Bn | 800.70 Mn | 22.09 |
| 5 | Aurora Cannabis | 15.07 Bn | 14.99 Bn | 21.72 Mn | -293.02 |
| 6 | Elanco Animal Health | 12.06 Bn | 11.63 Bn | 785.00 Mn | 13.64 |
| 7 | Hims & Hers Health | 8.09 Bn | 7.34 Bn | 396.79 Mn | -419.86 |
| 8 | Alkermes | 7.47 Bn | 6.96 Bn | -116.06 Mn | 45.99 |
| 9 | Lantheus Holdings | 6.69 Bn | 6.19 Bn | 230.92 Mn | 21.34 |
| 10 | Liquidia | 6.26 Bn | 6.03 Bn | 121.79 Mn | 132.47 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 18, 2026 | 45.99 |
| Jun 17, 2026 | 45.44 |
| Jun 16, 2026 | 45.02 |
| Jun 15, 2026 | 45.30 |
| Jun 12, 2026 | 45.24 |
| Jun 11, 2026 | 45.98 |
| Jun 10, 2026 | 44.75 |
| Jun 9, 2026 | 45.33 |
| Jun 8, 2026 | 43.25 |
| Jun 5, 2026 | 43.64 |
| Jun 4, 2026 | 44.28 |
| Jun 3, 2026 | 43.60 |
| Jun 2, 2026 | 42.01 |
| Jun 1, 2026 | 43.05 |
| May 29, 2026 | 42.97 |
| May 28, 2026 | 40.50 |
| May 27, 2026 | 38.47 |
| May 26, 2026 | 37.65 |
| May 22, 2026 | 37.05 |
| May 21, 2026 | 37.21 |